Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 4Plasma cell 1Lymphoid 1

Conditions

Lymphoma 89Lymphoma, Non-Hodgkin 86Precursor Cell Lymphoblastic Leukemia-Lymphoma 81Leukemia, Lymphocytic, Chronic, B-Cell 65Lymphoma, Large B-Cell, Diffuse 54Lymphoma, Follicular 50Burkitt Lymphoma 40Hodgkin Disease 39Recurrence 37Multiple Myeloma 33Leukemia, Myeloid, Acute 32Leukemia 32Lymphoma, Mantle-Cell 31Lymphoma, B-Cell 31Neoplasms 23Myelodysplastic Syndromes 22Hematologic Neoplasms 21Lymphoma, B-Cell, Marginal Zone 17Waldenstrom Macroglobulinemia 16Leukemia, Myelogenous, Chronic, BCR-ABL Positive 14Leukemia, B-Cell 14Sarcoma 13Lymphoma, T-Cell 11Lymphoma, Large-Cell, Anaplastic 11Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 10Lymphoma, T-Cell, Peripheral 10Glioma 10Osteosarcoma 9Neuroblastoma 9Mycosis Fungoides 9

Interventions

Specimen Handling 1CVnCoV COVID-19 vaccine 1COH04S1 COVID-19 vaccine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
COVID-19 × Lymphoid × 30 days × Clear all
NCT05672355 2026-05-20

A Vaccine Booster (GEO-CM04S1) for the Prevention of COVID-19 in Patients With Chronic Lymphocytic Leukemia

City of Hope Medical Center

Phase 2 Suspended
80 enrolled
LymphoidOther hematologic neoplasm

COVID-19, Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡